CarlGKardinalMD

PubMed

• 3 citations
  Altruism--a coping mechanism for patients on clinical trials: a nursing perspective.
  Judith Brown Sanders, Julie S. Seda, Carl G. Kardinal> ;Clinical Journal of Oncology Nursing. 2013 Sep 30
• 1 citations
  The changing hope trajectory in patients with advanced-stage cancer: a nursing perspective.
  Judith Brown Sanders, Julie S. Seda, Carl G. Kardinal> ;Clinical Journal of Oncology Nursing. 2012 May 28
• 23 citations
  Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
  Jessica M. Fleagle, Ravi Kiran Bobba, Carl G. Kardinal, Carl Freter> ;The American Journal of the Medical Sciences. 2012 Mar 1
• Altruism: A form of hope for patients with advanced cancer.
  Kardinal CG> ;J. Clin. Oncol.. 2011-05-20
• Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: Response to treatment with bevacizumab.
  Fleagle JM, Bobba RK, Khozouz RF, Garg P, Kardinal CG, Freter C> ;J. Clin. Oncol.. 2011-05-20
• Informed consent: Timely issues from the past. Factors motivating patients with advanced cancer to participate in phase II trials.
  Kardinal CG, Sanders JB, Cupper HT> ;J. Clin. Oncol.. 2009-05-20
• 58 citations
  Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
  Anthony L.A. Fields, Alan Keller, Lee S. Schwartzberg, Stephen A. Bernard, Carl Kardinal, Alan R. Cohen, Joe Schulz, Peter D. Eisenberg, John K. Forster, Paul Wissel> ;Journal of Clinical Oncology. 2009 Apr 20
• 7 citations
  Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group
  John T. Hamm, John W Wilson, Priya Rastogi, Barry C. Lembersky, George C. Tseng, Young K. Song, Wan Seop Kim, André Robidoux, Jane M. Raymond, Carl G. Kardinal, Ibrahi...> ;Clinical Breast Cancer. 2008 Jun 1
• 14 citations
  A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
  Scott H. Okuno, Robert Delaune, Jeff A. Sloan, Nathan R. Foster, Matthew J. Maurer, Marie Christine Aubry, Kendrith M. Rowland, Gamini S. Soori, Daniel A. Nikcevich, C...> ;Cancer. 2008 Apr 15
• 25 citations
  A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
  Walter M. Stadler, Apurva A. Desai, David I. Quinn, Ronald M. Bukowski, Bernard J. Poiesz, Carl G. Kardinal, Nancy L. Lewis, Alex Makalinao, Peter Murray, Frank M. Torti> ;Cancer Chemotherapy and Pharmacology. 2008 Apr 1
• 1 citations
  Hurricane katrina: the challenge to cancer clinical research.
  Carl G. Kardinal> ;Ochsner Journal. 2006 Jan 1
• 8 citations
  Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent met...
  Harry J. Long, Robert A. Nelimark, Karl C. Podratz, Vera J. Suman, Gary L. Keeney, Daniel A. Nikcevich, John W. Kugler, Kendrith M. Rowland, Carl G. Kardinal, Edward J...> ;Gynecologic Oncology. 2006 Mar 1
• 1 citations
  The ochsner cancer institute clinical trials program.
  Carl G. Kardinal, Marilyn Bateman> ;Ochsner Journal. 2006 Jan 1
• 86 citations
  Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastat...
  Edith A. Perez, Vera J. Suman, Kendrith M. Rowland, James N. Ingle, Muhammad Salim, Charles L. Loprinzi, Patrick J. Flynn, James A. Mailliard, Carl G. Kardinal, James ...> ;Clinical Breast Cancer. 2005 Dec 1
• 7 citations
  Investigating four ‘myths’ surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group*
  Aminah Jatoi, Nathan R. Foster, Patricia A. Johnson, George G. Klee, J F Quevedo, Roscoe F. Morton, Suresh G. Nair Md, Carl G. Kardinal, James A. Mailliard> ;Diseases of the Esophagus. 2004 Dec 1
• 96 citations
  Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both
  Edith A. Perez, David W. Hillman, James A. Mailliard, James N. Ingle, J. Michael Ryan, Tom R. Fitch, Kendrith M. Rowland, Carl G. Kardinal, James E. Krook, John W. Kug...> ;Journal of Clinical Oncology. 2004 Jul 15
• 63 citations
  Safety and Toxicity Analysis of Oxaliplatin Combined With Fluorouracil or as a Single Agent in Patients With Previously Treated Advanced Colorectal Cancer
  Ramesh K. Ramanathan, Jeffery W. Clark, Nancy E. Kemeny, Heinz-Josef Lenz, Kim O. Gococo, D. G. Haller, Edith P. Mitchell, Carl G. Kardinal> ;Journal of Clinical Oncology. 2003 Aug 1
• 73 citations
  Nicotine Patch Therapy Based on Smoking Rate Followed by Bupropion for Prevention of Relapse to Smoking
  Richard D. Hurt, James E. Krook, Ivana T. Croghan, Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, Carl G. Kardinal, James A. Knost, Maria Tria Tirona, Ferdinand ...> ;Journal of Clinical Oncology. 2003 Mar 1
• 18 citations
  Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
  Roy E. Smith, Stewart J. Anderson, Ann M. Brown, Aaron P. Scholnik, Ajit M. Desai, Carl G. Kardinal, Barry C. Lembersky, Eleftherios P. Mamounas> ;Clinical Breast Cancer. 2002 Dec 1
• 30 citations
  A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
  Aminah Jatoi, Marisa Tria Tirona, Steven Cha, Steven R. Alberts, Kendrith M. Rowland, Roscoe F. Morton, Suresh G. Nair Md, Carl G. Kardinal, Philip J. Stella, James A....> ;International Journal of Gastrointestinal Cancer. 2002 Jan 1
• 297 citations
  Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study
  Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi, Jeff A. Sloan, S. R. Dakhil, James A. Mailliard, Sarode Pundaleeka, Carl G. Kardinal, Tom R. Fitch, James E. K...> ;Journal of Clinical Oncology. 2002 Jan 15
• 57 citations
  A Simple Stratification Factor Prognostic for Survival in Advanced Cancer: The Good/Bad/Uncertain Index
  Jeff A. Sloan, Charles L. Loprinzi, John A. Laurine, Paul J. Novotny, Delfino Vargas-Chanes, James E. Krook, Michael J. O'Connell, John W. Kugler, Maria Tria Tirona, C...> ;Journal of Clinical Oncology. 2001 Aug 1
• 184 citations
  Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23
  B Fisher, Stewart J. Anderson, E. Tan-Chiu, Norman Wolmark, D. L. Wickerham, E. R. Fisher, N. V. Dimitrov, J. N. Atkins, N. Abramson, Sofia D. Merajver, E. H. Romond, ...> ;Journal of Clinical Oncology. 2001 Feb 15
• 750 citations
  2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines*
  , , , , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2000 Oct 20
• Can breast cancer be prevented
  Carl G. Kardinal, John T. Cole> ;Ochsner Journal. 2000 Jan 1
• Join now to see all